Free tool
Drug Trial Radar: Pain and anesthesia
Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
755
Completed, industry sponsors, Pain and anesthesia, Phase 2
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed755
755 trials
Showing 1 to 25, recently updated first.
- PK and Safety After C-SectionCompleted
Heron TherapeuticsIndustry
NCT03955211 · 25 participants · Start Jun 24, 2019 · Primary completion Dec 3, 2021
Drug: HTX-011; MMA regimen · For: Postoperative Pain
Sites: Sheffield, Alabama; San Diego, California; Durham, North Carolina · 4 sites in all
- A Phase Ⅱ/Ⅲ Study of HRS-2129 for Postsurgical Pain Management in Abdominal SurgeryPivotal-lookingCompleted
Shandong Suncadia Medicine Co., Ltd.Industry
NCT07185594 · 156 participants · Start Oct 24, 2025 · Primary completion Dec 31, 2025
Drug: HRS-2129 Tablets; Blank Preparation. and 1 more · For: Postoperative Analgesia
Sites: Zhengzhou, China; Hangzhou, China
- A Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive KeratectomyPivotal-lookingCompleted
Bausch & Lomb IncorporatedIndustry
NCT07412496 · 130 participants · Start Mar 31, 2026 · Primary completion Oct 4, 2026
Drug: Topical Ocular BL1332 low dose; Topical Ocular BL1332 high dose and 1 more · For: Pain, Postoperative
Sites: Scottsdale, Arizona; Long Beach, California; Pasadena, California · 15 sites in all
- Phase 2B Study Assessing Pain Relief After Replacement of the KneePivotal-lookingCompleted
Allay Therapeutics, Inc.Industry
NCT06799845 · 226 participants · Start Feb 3, 2025 · Primary completion Oct 3, 2025
Drug: ATX101; bupivacaine hydrochloride and 1 more · For: Total Knee Arthroplasty (Postoperative Pain)
Sites: Little Rock, Arkansas; Tamarac, Florida; Atlanta, Georgia · 11 sites in all
- Randomized, Double-blind, Placebo-controlled, Multicenter Phase IIb Clinical Trial of Spray YJ001 for the Treatment of Diabetic Peripheral Neuropathic PainPivotal-lookingCompleted
Zhejiang Yuejia Pharmaceuticals Co., Ltd.Industry
NCT07858344 · 196 participants · Start Jan 18, 2024 · Primary completion Dec 27, 2024
Drug: YJ001 spray simulator; YJ001 Spray 240 mg/day and 2 more · For: Diabetic Peripheral Neuropathic Pain (DPNP)
Sites: Beijing, China
- A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment in Orthopedic SurgeryPivotal-lookingCompleted
Haisco Pharmaceutical Group Co., Ltd.Industry
NCT07442877 · 161 participants · Start Sep 13, 2024 · Primary completion Jan 24, 2025
Drug: HSK21542 dose level 1; HSK21542 dose level 2 and 2 more · For: Postoperative Pain Management
Sites: Hefei, China; Guangzhou, China; Liuzhou, China · 27 sites in all
- Study of PHN131 in Patients After SurgeryPivotal-lookingCompleted
PhytoHealth CorporationIndustry
NCT02193620 · 106 participants · Start Apr 30, 2013 · Primary completion Sep 21, 2014
Drug: PHN131 soft capsule with Nalbuphine HCl 60 mg/cap; Placebo soft capsules and 1 more · For: Analgesia Disorder
Sites: Taipei, Taiwan
Millennium Pharmaceuticals, Inc.Takeda (TAK)
NCT03990649 · 24 participants · Start Jul 23, 2019 · Primary completion Jun 29, 2020
Drug: Soticlestat; Placebo · For: Complex Regional Pain Syndrome
Sites: London, United Kingdom; Preston, United Kingdom; Southampton, United Kingdom
- A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral NeuropathyPivotal-lookingCompleted
Novo Nordisk A/SNovo Nordisk (NVO)
NCT06797869 · 142 participants · Start Jan 29, 2025 · Primary completion Jun 26, 2026
Drug: CagriSema (Cagrilintide B and Semaglutide I); Placebo matched to CagriSema (Cagrilintide B and Semaglutide I) · For: Diabetes Mellitus, Type 2; Diabetic Peripheral Neuropathy
Sites: La Mesa, California; San Diego, California; Miami, Florida · 55 sites in all
- Efficacy and Safety of S (+) - Ibuprofen in Osteoarthritis PainPivotal-lookingCompleted
Apsen Farmaceutica S.A.Industry
NCT04637529 · 176 participants · Start Aug 5, 2022 · Primary completion Jun 30, 2023
Drug: S (+) - Ibuprofen; Ibuvix® - ibuprofen · For: Osteoarthritis
Sites: São Paulo, Brazil
Jiangsu HengRui Medicine Co., Ltd.Industry
NCT07446309 · 67 participants · Start Apr 10, 2026 · Primary completion Jul 14, 2026
Drug: HRS-9190; under Inhalational Anesthesia; HRS-9190; under Intravenous Anesthesia and 2 more · For: Neuromuscular Blockade
Sites: Shanghai, China; Taiyuan, China
- Efficacy and Safety of S (+) - Ibuprofen in the Treatment of Mechanical Low Back PainPivotal-lookingCompleted
Apsen Farmaceutica S.A.Industry
NCT04772781 · 177 participants · Start Jun 3, 2022 · Primary completion May 25, 2023
Drug: S (+) - Ibuprofen; Ibuflex® · For: Low Back Pain, Mechanical; Low Back Pain; Acute Low Back Pain
Sites: São Paulo, Brazil
ZYUS Life Sciences Inc.Industry
NCT06533657 · 11 participants · Start Jun 12, 2025 · Primary completion Apr 15, 2026
Drug: Trichomylin® capsule (5 mg delta-9-tetrahydrocannabinol: 5 mg cannabidiol: 5 mg cannabichromene) · For: Cancer Pain
Sites: Winnipeg, Canada; Montreal, Canada · 3 sites in all
- A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic PainPivotal-lookingCompleted
Eli Lilly and CompanyEli Lilly (LLY)
NCT06074562 · 404 participants · Start Oct 5, 2023 · Primary completion Jun 11, 2025
Drug: Mazisotine; Placebo · For: Diabetic Peripheral Neuropathy
Sites: Chandler, Arizona; Scottsdale, Arizona; Tucson, Arizona · 70 sites in all
GlaxoSmithKlineGSK (GSK)
NCT04494412 · 8 participants · Start Nov 21, 2022 · Primary completion Jan 14, 2026
Drug: Zanamivir · For: Influenza, Human; Arthralgia
Sites: Florence, Italy; Messina, Italy; Roma, Italy · 6 sites in all
- A Study of ONO-1110 in Patients With Postherpetic NeuralgiaPivotal-lookingCompleted
Ono Pharmaceutical Co., Ltd.Industry
NCT06708416 · 142 participants · Start Feb 12, 2025 · Primary completion May 11, 2026
Drug: ONO-1110; Placebo · For: Postherpetic Neuralgia
Sites: Aichi, Japan; Fukuoka, Japan; Fukushima, Japan · 31 sites in all
- A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.Pivotal-lookingCompleted
CinDome Pharma, Inc.Industry
NCT06899217 · 416 participants · Start Jan 29, 2025 · Primary completion May 7, 2026
Drug: CIN-102 Dose 15mg; Placebo and 1 more · For: Idiopathic Gastroparesis
Sites: Birmingham, Alabama; Foley, Alabama; Saraland, Alabama · 85 sites in all
- Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory PolyneuropathyPivotal-lookingCompleted
Eli Lilly and CompanyEli Lilly (LLY)
NCT06568042 · 558 participants · Start Aug 22, 2024 · Primary completion Jan 12, 2026
Drug: LY3848575; Placebo · For: Neuropathic Pain; Distal Sensory Polyneuropathy
Sites: Chandler, Arizona; Phoenix, Arizona; Fresno, California · 76 sites in all
Scilex Pharmaceuticals, Inc.Industry
NCT05096494 · 76 participants · Start Apr 29, 2022 · Primary completion May 30, 2023
Drug: SP-103; Placebo · For: Moderate to Severe Acute Lower Back Pain
Sites: Phoenix, Arizona; Fernandina Beach, Florida; Jacksonville, Florida · 10 sites in all
- Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to OsteoarthritisPivotal-lookingCompleted
ZetrOZ, Inc.Industry
NCT06257537 · 307 participants · Start Oct 1, 2024 · Primary completion Jun 26, 2026
Drug: 2.5% Diclofenac Patches · For: Osteo Arthritis Knee; Arthritis
Sites: Stamford, Connecticut; Trumbull, Connecticut; Dryden, New York
- A Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Orthopedic SurgeryPivotal-lookingCompleted
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.Industry
NCT06901830 · 150 participants · Start May 23, 2025 · Primary completion Dec 6, 2025
Drug: YZJ-4729; Placebo Comparator: Saline and 1 more · For: Pain
Sites: Changsha, China; Chengdu, China; Ch’ang-ch’un, China · 21 sites in all
- A Study of Medical Cannabis Aerosol Via the Fixed-dose Syqe Inhaler as an Add-on Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)Pivotal-lookingCompleted
Syqe MedicalIndustry
NCT06490445 · 122 participants · Start Nov 14, 2024 · Primary completion May 26, 2026
Drug: Medical Cannabis; Placebo · For: Diabetic Peripheral Neuropathic Pain
Sites: Waitara, Australia; Westmead, Australia; Camberwell, Australia · 38 sites in all
- A Phase Ⅱ Study to Evaluate the Efficacy and Safety of YZJ-4729 in Patients With Moderate to Severe Acute Pain After Abdominal SurgeryPivotal-lookingCompleted
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.Industry
NCT06680466 · 179 participants · Start Dec 26, 2023 · Primary completion Jul 15, 2024
Drug: YZJ-4729; morphine and 4 more · For: Pain
Sites: Changsha, China
- A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive TreatmentsPivotal-lookingCompleted
H. Lundbeck A/SIndustry
NCT06323928 · 874 participants · Start Apr 1, 2024 · Primary completion Jan 16, 2026
Drug: Lu AG09222; Placebo · For: Migraine
Sites: Hoover, Alabama; Carlsbad, California; Fullerton, California · 120 sites in all
Heron TherapeuticsIndustry
NCT04398329 · 78 participants · Start May 8, 2020 · Primary completion Jul 15, 2021
Drug: HTX-034 low dose; HTX-034 high dose and 1 more · For: Bunions; Postoperative Pain
Sites: Phoenix, Arizona; Bellaire, Texas; San Antonio, Texas · 4 sites in all
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.